ABL AND RD-BIOTECH SIGN STRATEGIC PARTNERSHIP IN CELL AND GENE THERAPY GMP MANUFACTURING
READ MORE
ABL AND IMUGENE PARTNER TO ADVANCE ONCOLYTIC VIRUS CANDIDATE TOWARDS LATER PHASE CLINICAL TRIALS
READ MORE
ABL PARTNERS WITH KALIVIR IMMUNOTHERAPEUTICS TO ADVANCE DEVELOPMENT OF ONCOLYTIC VIRUSES
Read more
COAVE THERAPEUTICS AND ABL ENTER INTO STRATEGIC COLLABORATION
Read more
ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY
Read more